• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

COVID-19 vaccine

FDA concludes Pfizer-BioNTech vaccine likely safe and effective in kids under 5

June 13, 2022 By Brian Buntz

In the U.S., COVID-19 vaccines are widely available to all age groups apart from children under the age of five. However, that could change this month now that FDA has signaled that three doses of the Pfizer-BioNTech (NYSE:PFE/Nasdaq BNTX) COVID-19 vaccine are likely effective against COVID-19 in an analysis ahead of a June 15 Vaccines […]

Filed Under: Blog, Featured, Pharmaceutical Tagged With: BioNTech, COVID-19 vaccine, Moderna, Pfizer

FDA allows booster dose Pfizer-BioNTech COVID-19 vaccine in children 5 to 11

May 17, 2022 By Brian Buntz

The Pfizer-BioNTech vaccine booster had been previously limited in the U.S. to individuals at least 12 years old, but now children as young as 5 are eligible, thanks to an expanded emergency use authorization related to the vaccine. The agency agreed to expand the vaccine’s use in children to “provide continued protection against COVID-19,” said […]

Filed Under: Blog, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: BioNTech, COVID-19 boosters, COVID-19 vaccine, Pfizer

Moderna seeks authorization for COVID-19 vaccine in children as young as 6 months old

April 28, 2022 By Brian Buntz

While a portion of the public is now eligible to receive a second booster dose of COVID-19 vaccine, the FDA has not yet authorized a vaccine for children aged 6 months to 5 years old. Moderna (Nasdaq:MRNA) is vying to be the first. The company announced today that it is filing a request for emergency […]

Filed Under: Blog, Featured, Pharmaceutical Tagged With: children, COVID-19 vaccine, Moderna, mRNA-1273

Takeda wins approval to distribute Novavax’s COVID-19 vaccine in Japan

April 20, 2022 By Brian Buntz

Takeda (NYSE:TAK) has announced that it has won manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for Nuvaxovid, a novel COVID-19 vaccine. Nuvaxovid (NVX-CoV2373) was initially developed by Novavax (Nasdaq:NVAX). The approval covers the use of the vaccine as both a primary and booster immunization in adults at least […]

Filed Under: Featured, News Well, Pharmaceutical Tagged With: coronavirus, COVID-19, COVID-19 vaccine, Novavax, Nuvaxovid, NVX-CoV2373, Takeda

Pfizer-BioNTech COVID-19 vaccine booster spurs strong immune response in kids 5–11

April 14, 2022 By Brian Buntz

Pfizer (NYSE:PFE) and BioNTech SE (Nasdaq:BNTX) have shared positive data from a Phase 2/3 clinical study testing a third 10-µg dose of the Pfizer-BioNTech COVID-19 vaccine in healthy children aged 5 through 11. The most recent data show that a booster dose of the BNT162b2 vaccine led to increased neutralizing titers for the omicron variant […]

Filed Under: Blog, Featured, Pharmaceutical Tagged With: BioNTech, booster, COVID-19 vaccine, Pfizer

FDA’s Woodcock reassures about COVID-19 tests, vaccines under Omicron

December 1, 2021 By Chris Newmarker

Acting FDA Commissioner Dr. Janet Woodcock thinks many COVID-19 tests will continue to work with the new Omicron variant — with information coming soon on vaccine efficacy. In a statement posted yesterday, Woodcock said she thought the agency is well-positioned to work with companies to address the potential impact of viral mutations on COVID-19 tests, […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: coronavirus, COVID-19, COVID-19 vaccine, FDA

FDA advisory panel recommends boosters only for older and high-risk individuals

September 17, 2021 By Brian Buntz

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously supported emergency use authorization to administer the Pfizer-BioNTech Comirnaty vaccine as a booster to those 65 years of age and older individuals at high risk of developing severe COVID-19. The panel, however, resoundingly rejected a plan to administer the vaccine as a booster to individuals […]

Filed Under: Featured, Pharmaceutical Tagged With: BioNTech, coronavirus, COVID-19, COVID-19 vaccine, COVID-19 vaccine trial, COVID-19 vaccines, FDA, Pfizer, Vaccines and Related Biological Products Advisory Committee, VRBPAC

COVID-19 vaccine booster tensions mount between White House, CDC and FDA

September 15, 2021 By Brian Buntz

Facing the second-biggest wave of COVID-19 infections and waning popularity, President Biden has promised to launch an initiative to begin providing vaccine boosters starting September 20.  But the plan hinges upon FDA and CDC support, and some officials at the agencies remain unconvinced that boosters are immediately necessary.  Two departing senior FDA vaccine officials recently co-wrote […]

Filed Under: Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: BioNTech, CDC, Centers for Disease Control & Prevention (CDC), COVID-19, COVID-19 vaccine, COVID-19 vaccine trial, FDA, Pfizer

FDA outlines plan to ‘follow the science’ as it mulls over COVID-19 vaccines for children

September 10, 2021 By Sean Whooley

FDA leaders have issued a statement regarding the agency’s plan moving forward with regards to authorizing COVID-19 vaccines for children. The FDA plans to “follow the science” with eyes on COVID-19 vaccines for children younger than 12 as schools begin to get back in session around the country, the agency said in a news release […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pediatrics, Pharmaceutical Tagged With: coronavirus, COVID-19, COVID-19 vaccine, FDA

Moderna submits initial data to FDA for COVID-19 vaccine booster

September 2, 2021 By Sean Whooley

Moderna (NSDQ:MRNA) announced that it initiated its submission to the FDA for a booster dose of its COVID-19 vaccine. Cambridge, Massachusetts-based Moderna expects to submit data to the European Medicines Agency and other regulatory authorities around the world in addition to the FDA in the coming days for the booster shot at a 50 µg dose […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: coronavirus, COVID-19, COVID-19 vaccine, Moderna

Pfizer seeks FDA blessing for COVID-19 vaccine booster

August 25, 2021 By Brian Buntz

Pfizer (NYSE:PFE) and its partner BioNTech (NSDQ:BNTX) aim to expand the recent FDA approval of their COVID-19 vaccine to include booster doses for individuals 16 and older. The companies have submitted a supplemental Biologics License Application to the FDA, including Phase 3 data drawn from participants aged 15 to 55. The latest data indicate that […]

Filed Under: Featured, Pharmaceutical Tagged With: BioNTech, Comirnaty, coronavirus, COVID-19, COVID-19 vaccine, COVID-19 vaccine trial, COVID-19 vaccines

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 9
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS